Cas no 588717-94-6 (1,3,2-Dioxaborolane, 2-(6-methoxy-1-naphthalenyl)-4,4,5,5-tetramethyl-)
1,3,2-Dioxaborolane, 2-(6-methoxy-1-naphthalenyl)-4,4,5,5-tetramethyl- Chemical and Physical Properties
Names and Identifiers
-
- 1,3,2-Dioxaborolane, 2-(6-methoxy-1-naphthalenyl)-4,4,5,5-tetramethyl-
- 2-(6-methoxynaphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
- 2-(6-Methoxy-naphthalen-1-yl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane
- SB37810
- AT25632
- DB-136648
- LRUMIJPWNGXDQH-UHFFFAOYSA-N
- 3-Hydroxy-3-methyloctanoic acid ethyl ester
- 588717-94-6
- 2-(6-methoxynaphthalen-1-yl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane
- (6-METHOXYNAPHTHALEN-1-YL)BORONIC ACID PINACOL ESTER
- SCHEMBL5780896
- DTXSID40623717
- MFCD22494563
-
- MDL: MFCD22494563
- Inchi: 1S/C17H21BO3/c1-16(2)17(3,4)21-18(20-16)15-8-6-7-12-11-13(19-5)9-10-14(12)15/h6-11H,1-5H3
- InChI Key: LRUMIJPWNGXDQH-UHFFFAOYSA-N
- SMILES: O1B(C2=CC=CC3C=C(C=CC2=3)OC)OC(C)(C)C1(C)C
Computed Properties
- Exact Mass: 283.16203
- Monoisotopic Mass: 284.1583747g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 21
- Rotatable Bond Count: 2
- Complexity: 366
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 27.7?2
Experimental Properties
- PSA: 27.69
1,3,2-Dioxaborolane, 2-(6-methoxy-1-naphthalenyl)-4,4,5,5-tetramethyl- Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 32R0282P-1g |
2-(6-Methoxy-naphthalen-1-yl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane |
588717-94-6 | 97% | 1g |
15943.2CNY | 2021-07-19 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 32R0282P-5g |
2-(6-Methoxy-naphthalen-1-yl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane |
588717-94-6 | 97% | 5g |
59346.01CNY | 2021-07-19 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 32R0282P-500mg |
2-(6-Methoxy-naphthalen-1-yl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane |
588717-94-6 | 97% | 500mg |
8463.46CNY | 2021-07-19 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 32R0282P-250mg |
2-(6-Methoxy-naphthalen-1-yl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane |
588717-94-6 | 97% | 250mg |
4655.75CNY | 2021-07-19 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 32R0282P-100mg |
2-(6-Methoxy-naphthalen-1-yl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane |
588717-94-6 | 97% | 100mg |
2756.14CNY | 2021-07-19 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 32R0282P-1g |
2-(6-Methoxy-naphthalen-1-yl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane |
588717-94-6 | 97% | 1g |
¥16438.61 | 2025-01-21 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 32R0282P-5g |
2-(6-Methoxy-naphthalen-1-yl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane |
588717-94-6 | 97% | 5g |
¥61190.09 | 2025-01-21 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 32R0282P-500mg |
2-(6-Methoxy-naphthalen-1-yl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane |
588717-94-6 | 97% | 500mg |
¥8726.45 | 2025-01-21 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 32R0282P-250mg |
2-(6-Methoxy-naphthalen-1-yl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane |
588717-94-6 | 97% | 250mg |
¥0.0 | 2025-01-21 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 32R0282P-100mg |
2-(6-Methoxy-naphthalen-1-yl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane |
588717-94-6 | 97% | 100mg |
¥0.0 | 2025-01-21 |
1,3,2-Dioxaborolane, 2-(6-methoxy-1-naphthalenyl)-4,4,5,5-tetramethyl- Related Literature
-
Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
-
Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
-
3. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
-
Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
-
Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
Additional information on 1,3,2-Dioxaborolane, 2-(6-methoxy-1-naphthalenyl)-4,4,5,5-tetramethyl-
Recent Advances in the Study of 1,3,2-Dioxaborolane, 2-(6-methoxy-1-naphthalenyl)-4,4,5,5-tetramethyl- (CAS: 588717-94-6)
The compound 1,3,2-Dioxaborolane, 2-(6-methoxy-1-naphthalenyl)-4,4,5,5-tetramethyl- (CAS: 588717-94-6) has garnered significant attention in recent years due to its versatile applications in medicinal chemistry and drug development. This boronic ester derivative is particularly notable for its role as a key intermediate in the synthesis of biologically active molecules, including proteasome inhibitors and other therapeutic agents. Recent studies have focused on optimizing its synthetic routes, exploring its reactivity, and evaluating its potential in targeted drug delivery systems.
One of the most promising areas of research involves the use of this compound in the development of boron-containing drugs, which leverage the unique properties of boron to enhance drug efficacy and selectivity. For instance, its incorporation into proteasome inhibitors has shown improved pharmacokinetic profiles and reduced off-target effects. Additionally, the compound's stability and reactivity make it an attractive candidate for Suzuki-Miyaura cross-coupling reactions, a cornerstone of modern synthetic chemistry.
Recent publications have also highlighted the compound's potential in imaging and diagnostics. Its fluorescent properties, derived from the naphthalene moiety, enable its use as a probe for detecting specific biomolecules in complex biological systems. This dual functionality—therapeutic and diagnostic—positions it as a valuable tool in the emerging field of theranostics.
Despite these advancements, challenges remain in scaling up the synthesis of 1,3,2-Dioxaborolane, 2-(6-methoxy-1-naphthalenyl)-4,4,5,5-tetramethyl- and ensuring its stability under physiological conditions. Ongoing research aims to address these issues by developing novel protective groups and optimizing reaction conditions. Furthermore, computational studies are being employed to predict its behavior in biological systems, thereby guiding experimental design.
In conclusion, the compound 1,3,2-Dioxaborolane, 2-(6-methoxy-1-naphthalenyl)-4,4,5,5-tetramethyl- (CAS: 588717-94-6) represents a promising avenue for future research in medicinal chemistry. Its multifaceted applications, from drug development to diagnostics, underscore its importance in the field. Continued exploration of its properties and potential will likely yield innovative solutions to current challenges in healthcare and biotechnology.
588717-94-6 (1,3,2-Dioxaborolane, 2-(6-methoxy-1-naphthalenyl)-4,4,5,5-tetramethyl-) Related Products
- 269410-26-6(phenoxyphenyl-4-boronic acid pinacol ester)
- 627526-43-6(1,3,2-DIOXABOROLANE, 2-(5-METHOXY-2-NAPHTHALENYL)-4,4,5,5-TETRAMETHYL-)
- 269410-16-4(2-(4-Methoxynaphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane)
- 171364-79-7(2-(4-Methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane)
- 627526-17-4(1,3,2-DIOXABOROLANE, 2-(5-METHOXY-1-NAPHTHALENYL)-4,4,5,5-TETRAMETHYL-)
- 269410-13-1(2-(6-methoxynaphthalen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane)
- 269410-05-1(2-Methoxy-1-Naphthaleneboronic Acid Pinacol Ester)
- 874673-97-9(1,3,2-Dioxaborolane,2-[6-(methoxymethoxy)-2-naphthalenyl]-4,4,5,5-tetramethyl-)
- 325142-84-5(3-Methoxyphenylboronic acid pinacol ester)
- 1260151-69-6(2-Hydroxy-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalene)